Biovail Corp. (NYSE: BVF) has acquired Prestwick Pharmaceuticals Inc., a Washington, D.C.-based drug company focused on CNS disorders, for $100 million in cash. Prestwick had raised around $120 million in total VC funding since 2002, from firms like Atlas Venture, Pequot Ventures, Scale Venture Partners, Sofinnova Ventures, Vivo Ventures and Warburg Pincus.
4 min read · 18 September 2008
Gregg Wurster has joined PCG Asset Management as a senior associate. He previously was a trader with hedge fund Alpha Vision Capital.
2 min read · 18 September 2008
3 min read · 18 September 2008
Eric Keller has agreed to join Kleiner Perkins Caufield & Byers as chief operating officer. He previously was CEO of enterprise software company Movaris, and before that was CFO of medical device company Ventritex.
2 min read · 18 September 2008
4 min read · 17 September 2008
1 min read · 17 September 2008
Chrysalis Ventures has closed its fourth fund with $175 million in capital commitments. New limited partners include Morgan Stanley, Credit Suisse, the Kentucky Teachers’ Retirement System and Health Evolution Partners. The Louisville, Ky.-based firm focuses on early-stage companies in the Midwest and South.
3 min read · 17 September 2008
UpTake, a Palo Alto, Calif.-based travel search and discovery engine, has raised $10 million in Series B funding co-led by Trinity Ventures and Shasta Ventures. The company had raised $4 million in Series A funding from Shasta late last year.
3 min read · 17 September 2008
3 min read · 17 September 2008
4 min read · 17 September 2008
